MELD remains the best predictor of mortality in outpatients with cirrhosis and severe ascites.

Jepsen, Peter; Watson, Hugh; Macdonald, Stewart; Vilstrup, Hendrik; Jalan, Rajiv

Jepsen, Peter; Watson, Hugh; Macdonald, Stewart; Vilstrup, Hendrik; Jalan, Rajiv.

Affiliation

Jepsen P; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Watson H; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Macdonald S; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Vilstrup H; Infectious Diseases Unit, Sanofi-Aventis R&D, Marcy l'Etoile, France.
Jalan R; Liver Failure Group, Institute for Liver and Digestive Health, University College London, London, UK.

Aliment Pharmacol Ther ; 52(3): 492-499, 2020 08.

Article in En | MEDLINE | ID: mdl-32573818

Subject(s)

Ascites/mortality; Liver Cirrhosis/mortality; Severity of Illness Index; Aged; Ascites/etiology; Female; Humans; Liver Cirrhosis/complications; Middle Aged; Outpatients; Prognosis; Quality of Life; Randomized Controlled Trials as Topic

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ascites / Severity of Illness Index / Liver Cirrhosis Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2020 Type: Article Affiliation country: Denmark

Fulltext

XML

PubMed Links

Search on Google